The global market for Atorvastatin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atorvastatin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atorvastatin API.
The Atorvastatin API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Atorvastatin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atorvastatin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jiangsu Alpha Pharmaceutical
Jiangsu Yutian Pharmaceutical
Lunan Pharmaceutical
Nanjing Dorra Pharmaceutical Technology
Menovo Pharmaceutical
Shree HariKrishna Pharmaceutical
Tenatra Chemie
Centrient Pharmaceuticals
Dr. Reddy's Laboratories
Teva API
Mangalam Drugs & Organics
Kyongbo Pharmaceutical
Apotex Pharmachem
Cadila Pharmaceuticals
Credo Life Sciences
by Type
0.99
0.995
0.999
Others
by Application
Medical Pharmaceutical
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atorvastatin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Atorvastatin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Atorvastatin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Atorvastatin API Market Overview
1.1 Product Definition
1.2 Atorvastatin API by Type
1.2.1 Global Atorvastatin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0.99
1.2.3 0.995
1.2.4 0.999
1.2.5 Others
1.3 Atorvastatin API by Application
1.3.1 Global Atorvastatin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medical Pharmaceutical
1.3.3 Scientific Research
1.4 Global Market Growth Prospects
1.4.1 Global Atorvastatin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Atorvastatin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Atorvastatin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Atorvastatin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Atorvastatin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Atorvastatin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Atorvastatin API, Industry Ranking, 2023 VS 2024
2.4 Global Atorvastatin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Atorvastatin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Atorvastatin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Atorvastatin API, Product Offered and Application
2.8 Global Key Manufacturers of Atorvastatin API, Date of Enter into This Industry
2.9 Atorvastatin API Market Competitive Situation and Trends
2.9.1 Atorvastatin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Atorvastatin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Atorvastatin API Production by Region
3.1 Global Atorvastatin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Atorvastatin API Production Value by Region (2020-2031)
3.2.1 Global Atorvastatin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Atorvastatin API by Region (2026-2031)
3.3 Global Atorvastatin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Atorvastatin API Production Volume by Region (2020-2031)
3.4.1 Global Atorvastatin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Atorvastatin API by Region (2026-2031)
3.5 Global Atorvastatin API Market Price Analysis by Region (2020-2025)
3.6 Global Atorvastatin API Production and Value, Year-over-Year Growth
3.6.1 North America Atorvastatin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Atorvastatin API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Atorvastatin API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Atorvastatin API Production Value Estimates and Forecasts (2020-2031)
4 Atorvastatin API Consumption by Region
4.1 Global Atorvastatin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Atorvastatin API Consumption by Region (2020-2031)
4.2.1 Global Atorvastatin API Consumption by Region (2020-2025)
4.2.2 Global Atorvastatin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Atorvastatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Atorvastatin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Atorvastatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Atorvastatin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Atorvastatin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Atorvastatin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Atorvastatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Atorvastatin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Atorvastatin API Production by Type (2020-2031)
5.1.1 Global Atorvastatin API Production by Type (2020-2025)
5.1.2 Global Atorvastatin API Production by Type (2026-2031)
5.1.3 Global Atorvastatin API Production Market Share by Type (2020-2031)
5.2 Global Atorvastatin API Production Value by Type (2020-2031)
5.2.1 Global Atorvastatin API Production Value by Type (2020-2025)
5.2.2 Global Atorvastatin API Production Value by Type (2026-2031)
5.2.3 Global Atorvastatin API Production Value Market Share by Type (2020-2031)
5.3 Global Atorvastatin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Atorvastatin API Production by Application (2020-2031)
6.1.1 Global Atorvastatin API Production by Application (2020-2025)
6.1.2 Global Atorvastatin API Production by Application (2026-2031)
6.1.3 Global Atorvastatin API Production Market Share by Application (2020-2031)
6.2 Global Atorvastatin API Production Value by Application (2020-2031)
6.2.1 Global Atorvastatin API Production Value by Application (2020-2025)
6.2.2 Global Atorvastatin API Production Value by Application (2026-2031)
6.2.3 Global Atorvastatin API Production Value Market Share by Application (2020-2031)
6.3 Global Atorvastatin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Jiangsu Alpha Pharmaceutical
7.1.1 Jiangsu Alpha Pharmaceutical Atorvastatin API Company Information
7.1.2 Jiangsu Alpha Pharmaceutical Atorvastatin API Product Portfolio
7.1.3 Jiangsu Alpha Pharmaceutical Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Jiangsu Alpha Pharmaceutical Main Business and Markets Served
7.1.5 Jiangsu Alpha Pharmaceutical Recent Developments/Updates
7.2 Jiangsu Yutian Pharmaceutical
7.2.1 Jiangsu Yutian Pharmaceutical Atorvastatin API Company Information
7.2.2 Jiangsu Yutian Pharmaceutical Atorvastatin API Product Portfolio
7.2.3 Jiangsu Yutian Pharmaceutical Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Jiangsu Yutian Pharmaceutical Main Business and Markets Served
7.2.5 Jiangsu Yutian Pharmaceutical Recent Developments/Updates
7.3 Lunan Pharmaceutical
7.3.1 Lunan Pharmaceutical Atorvastatin API Company Information
7.3.2 Lunan Pharmaceutical Atorvastatin API Product Portfolio
7.3.3 Lunan Pharmaceutical Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Lunan Pharmaceutical Main Business and Markets Served
7.3.5 Lunan Pharmaceutical Recent Developments/Updates
7.4 Nanjing Dorra Pharmaceutical Technology
7.4.1 Nanjing Dorra Pharmaceutical Technology Atorvastatin API Company Information
7.4.2 Nanjing Dorra Pharmaceutical Technology Atorvastatin API Product Portfolio
7.4.3 Nanjing Dorra Pharmaceutical Technology Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Nanjing Dorra Pharmaceutical Technology Main Business and Markets Served
7.4.5 Nanjing Dorra Pharmaceutical Technology Recent Developments/Updates
7.5 Menovo Pharmaceutical
7.5.1 Menovo Pharmaceutical Atorvastatin API Company Information
7.5.2 Menovo Pharmaceutical Atorvastatin API Product Portfolio
7.5.3 Menovo Pharmaceutical Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Menovo Pharmaceutical Main Business and Markets Served
7.5.5 Menovo Pharmaceutical Recent Developments/Updates
7.6 Shree HariKrishna Pharmaceutical
7.6.1 Shree HariKrishna Pharmaceutical Atorvastatin API Company Information
7.6.2 Shree HariKrishna Pharmaceutical Atorvastatin API Product Portfolio
7.6.3 Shree HariKrishna Pharmaceutical Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Shree HariKrishna Pharmaceutical Main Business and Markets Served
7.6.5 Shree HariKrishna Pharmaceutical Recent Developments/Updates
7.7 Tenatra Chemie
7.7.1 Tenatra Chemie Atorvastatin API Company Information
7.7.2 Tenatra Chemie Atorvastatin API Product Portfolio
7.7.3 Tenatra Chemie Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Tenatra Chemie Main Business and Markets Served
7.7.5 Tenatra Chemie Recent Developments/Updates
7.8 Centrient Pharmaceuticals
7.8.1 Centrient Pharmaceuticals Atorvastatin API Company Information
7.8.2 Centrient Pharmaceuticals Atorvastatin API Product Portfolio
7.8.3 Centrient Pharmaceuticals Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Centrient Pharmaceuticals Main Business and Markets Served
7.8.5 Centrient Pharmaceuticals Recent Developments/Updates
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Atorvastatin API Company Information
7.9.2 Dr. Reddy's Laboratories Atorvastatin API Product Portfolio
7.9.3 Dr. Reddy's Laboratories Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.9.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.10 Teva API
7.10.1 Teva API Atorvastatin API Company Information
7.10.2 Teva API Atorvastatin API Product Portfolio
7.10.3 Teva API Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Teva API Main Business and Markets Served
7.10.5 Teva API Recent Developments/Updates
7.11 Mangalam Drugs & Organics
7.11.1 Mangalam Drugs & Organics Atorvastatin API Company Information
7.11.2 Mangalam Drugs & Organics Atorvastatin API Product Portfolio
7.11.3 Mangalam Drugs & Organics Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Mangalam Drugs & Organics Main Business and Markets Served
7.11.5 Mangalam Drugs & Organics Recent Developments/Updates
7.12 Kyongbo Pharmaceutical
7.12.1 Kyongbo Pharmaceutical Atorvastatin API Company Information
7.12.2 Kyongbo Pharmaceutical Atorvastatin API Product Portfolio
7.12.3 Kyongbo Pharmaceutical Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Kyongbo Pharmaceutical Main Business and Markets Served
7.12.5 Kyongbo Pharmaceutical Recent Developments/Updates
7.13 Apotex Pharmachem
7.13.1 Apotex Pharmachem Atorvastatin API Company Information
7.13.2 Apotex Pharmachem Atorvastatin API Product Portfolio
7.13.3 Apotex Pharmachem Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Apotex Pharmachem Main Business and Markets Served
7.13.5 Apotex Pharmachem Recent Developments/Updates
7.14 Cadila Pharmaceuticals
7.14.1 Cadila Pharmaceuticals Atorvastatin API Company Information
7.14.2 Cadila Pharmaceuticals Atorvastatin API Product Portfolio
7.14.3 Cadila Pharmaceuticals Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Cadila Pharmaceuticals Main Business and Markets Served
7.14.5 Cadila Pharmaceuticals Recent Developments/Updates
7.15 Credo Life Sciences
7.15.1 Credo Life Sciences Atorvastatin API Company Information
7.15.2 Credo Life Sciences Atorvastatin API Product Portfolio
7.15.3 Credo Life Sciences Atorvastatin API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Credo Life Sciences Main Business and Markets Served
7.15.5 Credo Life Sciences Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Atorvastatin API Industry Chain Analysis
8.2 Atorvastatin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Atorvastatin API Production Mode & Process Analysis
8.4 Atorvastatin API Sales and Marketing
8.4.1 Atorvastatin API Sales Channels
8.4.2 Atorvastatin API Distributors
8.5 Atorvastatin API Customer Analysis
9 Atorvastatin API Market Dynamics
9.1 Atorvastatin API Industry Trends
9.2 Atorvastatin API Market Drivers
9.3 Atorvastatin API Market Challenges
9.4 Atorvastatin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Jiangsu Alpha Pharmaceutical
Jiangsu Yutian Pharmaceutical
Lunan Pharmaceutical
Nanjing Dorra Pharmaceutical Technology
Menovo Pharmaceutical
Shree HariKrishna Pharmaceutical
Tenatra Chemie
Centrient Pharmaceuticals
Dr. Reddy's Laboratories
Teva API
Mangalam Drugs & Organics
Kyongbo Pharmaceutical
Apotex Pharmachem
Cadila Pharmaceuticals
Credo Life Sciences
听
听
*If Applicable.
